Funding for this research was provided by:
Arthritis Research UK (20815, 19429, 21122)
Wellcome Trust (0944/Z/10/Z, Clinical Intermediate Fellowship)
Text and Data Mining valid from 2018-05-02
Received: 12 December 2017
Accepted: 21 March 2018
First Online: 2 May 2018
Ethics approval and consent to participate
: SF samples from patients undergoing ACI were collected under three independent ethical approvals: Investigating the potential for cells and molecules isolated from orthopaedic patients for modelling and understanding pathogenic conditions and developing diagnostic markers and therapies for musculoskeletal disorders and spinal cord injury (National Research Ethics Service [NRES] committee North West – Liverpool East 11/NW/0875), Autologous cell therapy for Osteoarthritis: An evaluation of the safety and efficacy of autologous transplantation of articular chondrocytes and/or bone marrow derived stromal cells to repair chondral/osteochondral lesions of the knee (NRES committee West Midlands – Coventry and Warwickshire 11/WM/0175), and Arthritis and cartilage repair study (Shropshire and Staffordshire-Shropshire local research ethics committee 06/Q6201/9). All patients gave valid informed consent prior to their samples’ being collected.
: Not applicable for this study.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.